Skip to main content
Premium Trial:

Request an Annual Quote

Avalon to License Ingenuity s Pathway Software

NEW YORK, Jan. 10 (GenomeWeb News) - Avalon Pharmaceuticals will license the Pathway Analysis 3.0 application from Ingenuity Systems to facilitate drug discovery, the companies said today.


Avalon will apply the software to its AvalonRx platform to identify biomarkers, targets, and novel compounds. The company will also have access to the Ingenuity Knowledge Base, which contains 1.4 million biological relationships between genes and proteins, cells, tissues, and diseases.


Financial details were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.